up-regulated collagen 1 and aSMA protein expression in response to IL-4 or IL-13 treatment. These effects were ablated through co-treatment with IL-4 and IL-13 receptors antibodies. Low concentrations of IL-4 and IL-13 significantly up-regulated N1 and primary prostate cell proliferation. Prostate fibroblasts treated with IL-4 or IL-13 significantly and almost equivalently up-regulated IL-13 protein expression, suggesting the establishment of an autocrine IL-13 expression loop. Treatment with IL-4 alone up-regulated IL-4, but not IL-13, protein expression. Neither IL-4 nor IL-13 affected TGFbeta expression levels.
INTRODUCTION AND OBJECTIVES:
Benign prostatic hyperplasia (BPH) is one of the most common prostatic disorders affecting aging men, causing progressive lower urinary tract symptoms (LUTS) such as bladder outlet obstruction (BOO). While ultrasound imaging is the current standard of care in monitoring human BPH, magnetic resonance imaging (MRI) offers enhanced image resolution. BPH may result from hormonemediated aberrant proliferation of prostate progenitor cells. Lack of sufficient in vivo models has made this hypothesis difficult to test directly. The objective of this study was to evaluate a recently published murine model of BOO/BPH via longitudinal MR imaging and immunohistochemistry to further understand the underpinning mechanisms of BPH/BOO pathophysiology.
METHODS: We adapted a recently published model of prostatic enlargement in order to investigate proliferating cell populations. Briefly, post-pubescent male mice were castrated and surgically implanted with subcutaneous implants to slowly release either testosterone (T) only or testosterone and estradiol (E). Mice were evaluated using MRI at 2-4 week intervals post-castration and then sacrificed accordingly. MR imaging was used to determine prostatic, urethral, and genitourinary blood volumes. Immunohistochemistry (IHC) was used to determine proliferating cell populations and prostate lineage changes.
RESULTS: We observed a significant increase, approximately 2-fold, in the prostatic volume of mice treated with T+E as compared to T controls (p ¼ 0.01) with a concomitant decrease in urethral volume (p ¼ 0.01). T+E mice also had significantly higher genitourinary blood volumes (p ¼ 0.01), indicating more genitourinary vascularization. We found no significant difference in number of CK8+ luminal cells, CK5+ basal cells, or Ki67+ epithelial cells.
CONCLUSIONS: Using MRI and IHC, we demonstrate that longterm treatment of mice with testosterone and estradiol induces an increase in prostatic volume with a concomitant decrease in urethral volume. Despite prostatic enlargement, we did not document an increase in proliferating prostatic epithelial cells or inflammatory infiltrate. Refining murine models is essential to understanding human BPH etiology and pathology. These data are critical to development of novel strategies that target progenitor cell populations in BPH, an unmet therapeutic need.
Source of Funding: EMM is supported by an F31 (F31DK111131). DVG is supported by an R01 (CA178431).
MP17-14 DEPLETION OF PERIPHERAL SEROTONIN SYNTHESIS INDUCES BENIGN PROSTATIC GROWTH IN MICE: MORE EVIDENCE FOR THE NEW "NEUROENDOCRINE THEORY" IN BPH ETIOLOGY
Paulo Mota*, Emanuel Carvalho-Dias, Alice Miranda, Olga Martinho, Cristina Nogueira-Silva, Braga, Portugal; Natalia Alenina, Michael Bader, Berlin, Germany; Riccardo Autorino, Estevão Lima, Jorge Correia-Pinto, Braga, Portugal INTRODUCTION AND OBJECTIVES: Ageing and testosterone cause almost inexorably benign prostatic hyperplasia (BPH) in Human males, however the etiology of BPH is unknown. Serotonin (5-HT) is produced by neuroendocrine prostatic cells and is present in high concentration in normal prostatic transition zone. In BPH neuroendocrine cells and 5-HT are significantly decreased comparatively to normal prostatic transition zone. Previously, we have demonstrated in several in vitro models that 5-HT inhibitis non-malignant prostatic growth through androgen receptor down-regulation and we suggested a new Neuroendocrine Theory for BPH etiology. Here, we investigated in vivo the effects of peripheral inhibition of 5-HT synthesis on mice prostate gland.
METHODS: peripheral 5-HT synthesis is critical dependent of the presence of TPH1, so we used transgenic mice depleted from TPH1 (Tph1-/-) to study the in vivo effect of peripheral serotonin depletion. Male wild-type and Tph1-/-mice were sacrificed at different time points: 7, 12, 16 and 20 weeks-old. For pharmacological studies, wild-type and Tph1-/-mice with 19 week-old were treated with daily intraperitoneal injections of 0,9% saline or 5-HT (100 mg/Kg) during 10 consecutive days.Prostate gland mass was determined and proceeded for histology, western blotting, immunofluorescence and qRT-PCR of AR expression.
RESULTS: We showed that Tph1 knockout mice depleted from peripheral 5-HT have significant higher prostate mass comparatively to wild-type (p < 0,001) and 5-HT treatment of Tph1 knockout mice restores prostate mass to levels of wild-type (p < 0,001) ( figure A and B) . We demonstrated also that the benign prostatic growth in Tph1 knockout mice is associated with up-regulation of AR and 5-HT treatment restores de expression of AR (p<0,05) ( Figure C and D) .
CONCLUSIONS: In vivo, 5-HT depletion induces benign prostatic growth in mice trough AR up-regulation. 5-HT depletion in transition zone of aging human male could be the etiologic factor for BPH etiology.
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